APO Research
Talk to an analyst

APO RESEARCH · REPORT

Non-invasive Insulin

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Non-invasive Insulin Industry Growth and Trends Forecast to 2032

27 December 2025106 pages

Choose your research edition.

Industry ResearchNon-invasive Insulin Industry Research Report 2026126 pages · $2,950 USDIndustry Growth & TrendsGlobal Non-invasive Insulin Industry Growth and Trends Forecast to 2032106 pages · $3,450 USDMarket StructureGlobal Non-invasive Insulin Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Non-invasive Insulin Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Non-invasive Insulin Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Non-invasive Insulin market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Non-invasive Insulin is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Non-invasive Insulin is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Non-invasive Insulin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Non-invasive Insulin include Sanofi, Novo Nordisk, Eli Lilly, Biocon, Zafgen, Verily Life Sciences, Senseonics, Oramed Pharmaceuticals and Medtronic, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Non-invasive Insulin market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Non-invasive Insulin market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Non-invasive Insulin market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Non-invasive Insulin.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Non-invasive Insulin market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Non-invasive Insulin Market by Company

Sanofi

Novo Nordisk

Eli Lilly

Biocon

Zafgen

Verily Life Sciences

Senseonics

Oramed Pharmaceuticals

Medtronic

MannKind Corporation

Janssen Pharmaceuticals

Dance Biopharm

Bigfoot Biomedical

Adocia

Non-invasive Insulin Segment by Type

Pills

Sprays

Others

Non-invasive Insulin Segment by Application

Hospital Pharmacies

Online Pharmacies

Drug Stores

Non-invasive Insulin Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Non-invasive Insulin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Non-invasive Insulin and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Non-invasive Insulin.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Non-invasive Insulin manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Non-invasive Insulin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Pills Table 2. Major Company of Sprays Table 3. Major Company of Others Table 4. Global Non-invasive Insulin Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Non-invasive Insulin Sales by Type (2021-2026) & (K Units) Table 6. Global Non-invasive Insulin Sales Market Share in Volume by Type (2021-2026) Table 7. Global Non-invasive Insulin Sales by Type (2021-2026) & (US$ Million) Table 8. Global Non-invasive Insulin Sales Market Share in Value by Type (2021-2026) Table 9. Global Non-invasive Insulin Price by Type (2021-2026) & (US$/Unit) Table 10. Global Non-invasive Insulin Sales by Type (2027-2032) & (K Units) Table 11. Global Non-invasive Insulin Sales Market Share in Volume by Type (2027-2032) Table 12. Global Non-invasive Insulin Sales by Type (2027-2032) & (US$ Million) Table 13. Global Non-invasive Insulin Sales Market Share in Value by Type (2027-2032) Table 14. Global Non-invasive Insulin Price by Type (2027-2032) & (US$/Unit) Table 15. North America Non-invasive Insulin Sales by Type (2021-2026) & (K Units) Table 16. North America Non-invasive Insulin Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Non-invasive Insulin Sales by Type (2021-2026) & (K Units) Table 18. Europe Non-invasive Insulin Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Non-invasive Insulin Sales by Type (2021-2026) & (K Units) Table 20. Asia-Pacific Non-invasive Insulin Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Non-invasive Insulin Sales by Type (2021-2026) & (K Units) Table 22. Latin America Non-invasive Insulin Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Non-invasive Insulin Sales by Type (2021-2026) & (K Units) Table 24. Middle East and Africa Non-invasive Insulin Sales by Type (2021-2026) & (US$ Million) Table 25. Non-invasive Insulin Industry Trends Table 26. Non-invasive Insulin Industry Drivers Table 27. Non-invasive Insulin Industry Opportunities and Challenges Table 28. Non-invasive Insulin Industry Restraints Table 29. Global Non-invasive Insulin Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Non-invasive Insulin Revenue Market Share by Company (2021-2026) Table 31. Global Non-invasive Insulin Sales by Company (2021-2026) & (K Units) Table 32. Global Non-invasive Insulin Sales Share by Company (2021-2026) Table 33. Global Non-invasive Insulin Market Price by Company (2021-2026) & (US$/Unit) Table 34. Global Non-invasive Insulin Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Non-invasive Insulin Major Company Production Sites and Headquarters Table 36. Global Non-invasive Insulin Company, Product Type & Application Table 37. Global Non-invasive Insulin Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Non-invasive Insulin by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Non-invasive Insulin Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Non-invasive Insulin Sales by Region (2021-2026) & (K Units) Table 42. Global Non-invasive Insulin Sales Market Share in Volume by Region (2021-2026) Table 43. Global Non-invasive Insulin Sales by Region (2021-2026) & (US$ Million) Table 44. Global Non-invasive Insulin Sales Market Share in Value by Region (2021-2026) Table 45. Global Non-invasive Insulin Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Global Non-invasive Insulin Sales by Region (2027-2032) & (K Units) Table 47. Global Non-invasive Insulin Sales Market Share in Volume by Region (2027-2032) Table 48. Global Non-invasive Insulin Sales by Region (2027-2032) & (US$ Million) Table 49. Global Non-invasive Insulin Sales Market Share in Value by Region (2027-2032) Table 50. Global Non-invasive Insulin Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 51. Global Non-invasive Insulin Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Non-invasive Insulin Sales by Application (2021-2026) & (K Units) Table 53. Global Non-invasive Insulin Sales Market Share in Volume by Application (2021-2026) Table 54. Global Non-invasive Insulin Sales by Application (2021-2026) & (US$ Million) Table 55. Global Non-invasive Insulin Sales Market Share in Value by Application (2021-2026) Table 56. Global Non-invasive Insulin Price by Application (2021-2026) & (US$/Unit) Table 57. Global Non-invasive Insulin Sales by Application (2027-2032) & (K Units) Table 58. Global Non-invasive Insulin Sales Market Share in Volume by Application (2027-2032) Table 59. Global Non-invasive Insulin Sales by Application (2027-2032) & (US$ Million) Table 60. Global Non-invasive Insulin Sales Market Share in Value by Application (2027-2032) Table 61. Global Non-invasive Insulin Price by Application (2027-2032) & (US$/Unit) Table 62. North America Non-invasive Insulin Sales by Application (2021-2026) & (K Units) Table 63. North America Non-invasive Insulin Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Non-invasive Insulin Sales by Application (2021-2026) & (K Units) Table 65. Europe Non-invasive Insulin Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Non-invasive Insulin Sales by Application (2021-2026) & (K Units) Table 67. Asia-Pacific Non-invasive Insulin Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Non-invasive Insulin Sales by Application (2021-2026) & (K Units) Table 69. Latin America Non-invasive Insulin Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Non-invasive Insulin Sales by Application (2021-2026) & (K Units) Table 71. Middle East and Africa Non-invasive Insulin Sales by Application (2021-2026) & (US$ Million) Table 72. Sanofi Company Information Table 73. Sanofi Business Overview Table 74. Sanofi Non-invasive Insulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Sanofi Non-invasive Insulin Product Portfolio Table 76. Sanofi Recent Development Table 77. Novo Nordisk Company Information Table 78. Novo Nordisk Business Overview Table 79. Novo Nordisk Non-invasive Insulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Novo Nordisk Non-invasive Insulin Product Portfolio Table 81. Novo Nordisk Recent Development Table 82. Eli Lilly Company Information Table 83. Eli Lilly Business Overview Table 84. Eli Lilly Non-invasive Insulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Eli Lilly Non-invasive Insulin Product Portfolio Table 86. Eli Lilly Recent Development Table 87. Biocon Company Information Table 88. Biocon Business Overview Table 89. Biocon Non-invasive Insulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Biocon Non-invasive Insulin Product Portfolio Table 91. Biocon Recent Development Table 92. Zafgen Company Information Table 93. Zafgen Business Overview Table 94. Zafgen Non-invasive Insulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Zafgen Non-invasive Insulin Product Portfolio Table 96. Zafgen Recent Development Table 97. Verily Life Sciences Company Information Table 98. Verily Life Sciences Business Overview Table 99. Verily Life Sciences Non-invasive Insulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. Verily Life Sciences Non-invasive Insulin Product Portfolio Table 101. Verily Life Sciences Recent Development Table 102. Senseonics Company Information Table 103. Senseonics Business Overview Table 104. Senseonics Non-invasive Insulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. Senseonics Non-invasive Insulin Product Portfolio Table 106. Senseonics Recent Development Table 107. Oramed Pharmaceuticals Company Information Table 108. Oramed Pharmaceuticals Business Overview Table 109. Oramed Pharmaceuticals Non-invasive Insulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. Oramed Pharmaceuticals Non-invasive Insulin Product Portfolio Table 111. Oramed Pharmaceuticals Recent Development Table 112. Medtronic Company Information Table 113. Medtronic Business Overview Table 114. Medtronic Non-invasive Insulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 115. Medtronic Non-invasive Insulin Product Portfolio Table 116. Medtronic Recent Development Table 117. MannKind Corporation Company Information Table 118. MannKind Corporation Business Overview Table 119. MannKind Corporation Non-invasive Insulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 120. MannKind Corporation Non-invasive Insulin Product Portfolio Table 121. MannKind Corporation Recent Development Table 122. Janssen Pharmaceuticals Company Information Table 123. Janssen Pharmaceuticals Business Overview Table 124. Janssen Pharmaceuticals Non-invasive Insulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 125. Janssen Pharmaceuticals Non-invasive Insulin Product Portfolio Table 126. Janssen Pharmaceuticals Recent Development Table 127. Dance Biopharm Company Information Table 128. Dance Biopharm Business Overview Table 129. Dance Biopharm Non-invasive Insulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 130. Dance Biopharm Non-invasive Insulin Product Portfolio Table 131. Dance Biopharm Recent Development Table 132. Bigfoot Biomedical Company Information Table 133. Bigfoot Biomedical Business Overview Table 134. Bigfoot Biomedical Non-invasive Insulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 135. Bigfoot Biomedical Non-invasive Insulin Product Portfolio Table 136. Bigfoot Biomedical Recent Development Table 137. Adocia Company Information Table 138. Adocia Business Overview Table 139. Adocia Non-invasive Insulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 140. Adocia Non-invasive Insulin Product Portfolio Table 141. Adocia Recent Development Table 142. North America Non-invasive Insulin Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 143. North America Non-invasive Insulin Sales by Country (2021-2026) & (K Units) Table 144. North America Non-invasive Insulin Sales Market Share by Country (2021-2026) Table 145. North America Non-invasive Insulin Sales Forecast by Country (2027-2032) & (K Units) Table 146. North America Non-invasive Insulin Sales Market Share Forecast by Country (2027-2032) Table 147. North America Non-invasive Insulin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 148. North America Non-invasive Insulin Market Size by Country (2021-2026) & (US$ Million) Table 149. North America Non-invasive Insulin Market Share by Country (2021-2026) Table 150. North America Non-invasive Insulin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 151. North America Non-invasive Insulin Market Share Forecast by Country (2027-2032) Table 152. Europe Non-invasive Insulin Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 153. Europe Non-invasive Insulin Sales by Country (2021-2026) & (K Units) Table 154. Europe Non-invasive Insulin Sales Market Share by Country (2021-2026) Table 155. Europe Non-invasive Insulin Sales Forecast by Country (2027-2032) & (K Units) Table 156. Europe Non-invasive Insulin Sales Market Share Forecast by Country (2027-2032) Table 157. Europe Non-invasive Insulin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 158. Europe Non-invasive Insulin Market Size by Country (2021-2026) & (US$ Million) Table 159. Europe Non-invasive Insulin Market Share by Country (2021-2026) Table 160. Europe Non-invasive Insulin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 161. Europe Non-invasive Insulin Market Share Forecast by Country (2027-2032) Table 162. Asia-Pacific Non-invasive Insulin Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 163. Asia-Pacific Non-invasive Insulin Sales by Country (2021-2026) & (K Units) Table 164. Asia-Pacific Non-invasive Insulin Sales Market Share by Country (2021-2026) Table 165. Asia-Pacific Non-invasive Insulin Sales Forecast by Country (2027-2032) & (K Units) Table 166. Asia-Pacific Non-invasive Insulin Sales Market Share Forecast by Country (2027-2032) Table 167. Asia-Pacific Non-invasive Insulin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 168. Asia-Pacific Non-invasive Insulin Market Size by Country (2021-2026) & (US$ Million) Table 169. Asia-Pacific Non-invasive Insulin Market Share by Country (2021-2026) Table 170. Asia-Pacific Non-invasive Insulin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 171. Asia-Pacific Non-invasive Insulin Market Share Forecast by Country (2027-2032) Table 172. Latin America Non-invasive Insulin Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 173. Latin America Non-invasive Insulin Sales by Country (2021-2026) & (K Units) Table 174. Latin America Non-invasive Insulin Sales Market Share by Country (2021-2026) Table 175. Latin America Non-invasive Insulin Sales Forecast by Country (2027-2032) & (K Units) Table 176. Latin America Non-invasive Insulin Sales Market Share Forecast by Country (2027-2032) Table 177. Latin America Non-invasive Insulin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 178. Latin America Non-invasive Insulin Market Size by Country (2021-2026) & (US$ Million) Table 179. Latin America Non-invasive Insulin Market Share by Country (2021-2026) Table 180. Latin America Non-invasive Insulin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 181. Latin America Non-invasive Insulin Market Share Forecast by Country (2027-2032) Table 182. Middle East and Africa Non-invasive Insulin Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 183. Middle East and Africa Non-invasive Insulin Sales by Country (2021-2026) & (K Units) Table 184. Middle East and Africa Non-invasive Insulin Sales Market Share by Country (2021-2026) Table 185. Middle East and Africa Non-invasive Insulin Sales Forecast by Country (2027-2032) & (K Units) Table 186. Middle East and Africa Non-invasive Insulin Sales Market Share Forecast by Country (2027-2032) Table 187. Middle East and Africa Non-invasive Insulin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 188. Middle East and Africa Non-invasive Insulin Market Size by Country (2021-2026) & (US$ Million) Table 189. Middle East and Africa Non-invasive Insulin Market Share by Country (2021-2026) Table 190. Middle East and Africa Non-invasive Insulin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 191. Middle East and Africa Non-invasive Insulin Market Share Forecast by Country (2027-2032) Table 192. Key Raw Materials Table 193. Raw Materials Key Suppliers Table 194. Non-invasive Insulin Distributors List Table 195. Non-invasive Insulin Customers List Table 196. Research Programs/Design for This Report Table 197. Authors List of This Report Table 198. Secondary Sources Table 199. Primary Sources List of Figures Figure 1. Non-invasive Insulin Image Figure 2. Global Non-invasive Insulin Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Non-invasive Insulin Market Size (2021-2032) & (US$ Million) Figure 4. Global Non-invasive Insulin Sales (2021-2032) & (K Units) Figure 5. Pills Image Figure 6. Global Pills Sales YoY Growth (2021-2032) & (K Units) Figure 7. Sprays Image Figure 8. Global Sprays Sales YoY Growth (2021-2032) & (K Units) Figure 9. Others Image Figure 10. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 11. Global Non-invasive Insulin Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Non-invasive Insulin Market Share by Type 2025 VS 2032 Figure 13. North America Non-invasive Insulin Sales Market Share in Volume by Type in 2025 Figure 14. North America Non-invasive Insulin Sales Market Share in Value by Type in 2025 Figure 15. Europe Non-invasive Insulin Sales Market Share in Volume by Type in 2025 Figure 16. Europe Non-invasive Insulin Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Non-invasive Insulin Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Non-invasive Insulin Sales Market Share in Value by Type in 2025 Figure 19. Latin America Non-invasive Insulin Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Non-invasive Insulin Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Non-invasive Insulin Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Non-invasive Insulin Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Non-invasive Insulin Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Hospital Pharmacies Image Figure 26. Global Hospital Pharmacies Sales YoY Growth (2021-2032) & (K Units) Figure 27. Online Pharmacies Image Figure 28. Global Online Pharmacies Sales YoY Growth (2021-2032) & (K Units) Figure 29. Drug Stores Image Figure 30. Global Drug Stores Sales YoY Growth (2021-2032) & (K Units) Figure 31. Global Non-invasive Insulin Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Non-invasive Insulin Market Share by Application 2025 VS 2032 Figure 33. North America Non-invasive Insulin Sales Market Share in Volume by Application in 2025 Figure 34. North America Non-invasive Insulin Sales Market Share in Value by Application in 2025 Figure 35. Europe Non-invasive Insulin Sales Market Share in Volume by Application in 2025 Figure 36. Europe Non-invasive Insulin Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Non-invasive Insulin Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Non-invasive Insulin Sales Market Share in Value by Application in 2025 Figure 39. Latin America Non-invasive Insulin Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Non-invasive Insulin Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Non-invasive Insulin Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Non-invasive Insulin Sales Market Share in Value by Application in 2025 Figure 43. North America Non-invasive Insulin Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 44. North America Non-invasive Insulin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Non-invasive Insulin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Non-invasive Insulin Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Non-invasive Insulin Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. Europe Non-invasive Insulin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Non-invasive Insulin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Non-invasive Insulin Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Non-invasive Insulin Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Asia-Pacific Non-invasive Insulin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Non-invasive Insulin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Non-invasive Insulin Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Non-invasive Insulin Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Latin America Non-invasive Insulin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Non-invasive Insulin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Non-invasive Insulin Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Non-invasive Insulin Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 60. Middle East and Africa Non-invasive Insulin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Non-invasive Insulin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Non-invasive Insulin Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Non-invasive Insulin Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Non-invasive Insulin Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Pills
  • Sprays
  • Others
Applications
  • Hospital Pharmacies
  • Online Pharmacies
  • Drug Stores
Companies covered
  • Sanofi
  • Novo Nordisk
  • Eli Lilly
  • Biocon
  • Zafgen
  • Verily Life Sciences
  • Senseonics
  • Oramed Pharmaceuticals
  • Medtronic
  • MannKind Corporation
  • Janssen Pharmaceuticals
  • Dance Biopharm
  • Bigfoot Biomedical
  • Adocia

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Non-invasive Insulin Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Non-invasive Insulin Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Non-invasive Insulin Market by Type
  6. 1.3.1 Pills
  7. 1.3.2 Sprays
  8. 1.3.3 Others
  9. 1.4 Global Non-invasive Insulin Market Size by Type
  10. 1.4.1 Global Non-invasive Insulin Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Non-invasive Insulin Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Non-invasive Insulin Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Non-invasive Insulin Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Non-invasive Insulin Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Non-invasive Insulin Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Non-invasive Insulin Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Non-invasive Insulin Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Non-invasive Insulin Industry Trends
  2. 2.2 Non-invasive Insulin Industry Drivers
  3. 2.3 Non-invasive Insulin Industry Opportunities and Challenges
  4. 2.4 Non-invasive Insulin Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Non-invasive Insulin Revenue (2021-2026)
  2. 3.2 Global Top Players by Non-invasive Insulin Sales (2021-2026)
  3. 3.3 Global Top Players by Non-invasive Insulin Price (2021-2026)
  4. 3.4 Global Non-invasive Insulin Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Non-invasive Insulin Major Company Production Sites & Headquarters
  6. 3.6 Global Non-invasive Insulin Company, Product Type & Application
  7. 3.7 Global Non-invasive Insulin Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Non-invasive Insulin Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Non-invasive Insulin Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Non-invasive Insulin Tier 1, Tier 2, and Tier 3
4 Non-invasive Insulin Regional Status and Outlook
  1. 4.1 Global Non-invasive Insulin Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Non-invasive Insulin Historic Market Size by Region
  3. 4.2.1 Global Non-invasive Insulin Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Non-invasive Insulin Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Non-invasive Insulin Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Non-invasive Insulin Forecasted Market Size by Region
  7. 4.3.1 Global Non-invasive Insulin Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Non-invasive Insulin Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Non-invasive Insulin Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Non-invasive Insulin by Application
  1. 5.1 Non-invasive Insulin Market by Application
  2. 5.1.1 Hospital Pharmacies
  3. 5.1.2 Online Pharmacies
  4. 5.1.3 Drug Stores
  5. 5.2 Global Non-invasive Insulin Market Size by Application
  6. 5.2.1 Global Non-invasive Insulin Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Non-invasive Insulin Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Non-invasive Insulin Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Non-invasive Insulin Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Non-invasive Insulin Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Non-invasive Insulin Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Non-invasive Insulin Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Non-invasive Insulin Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Sanofi
  2. 6.1.1 Sanofi Company Information
  3. 6.1.2 Sanofi Business Overview
  4. 6.1.3 Sanofi Non-invasive Insulin Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Sanofi Non-invasive Insulin Product Portfolio
  6. 6.1.5 Sanofi Recent Developments
  7. 6.2 Novo Nordisk
  8. 6.2.1 Novo Nordisk Company Information
  9. 6.2.2 Novo Nordisk Business Overview
  10. 6.2.3 Novo Nordisk Non-invasive Insulin Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Novo Nordisk Non-invasive Insulin Product Portfolio
  12. 6.2.5 Novo Nordisk Recent Developments
  13. 6.3 Eli Lilly
  14. 6.3.1 Eli Lilly Company Information
  15. 6.3.2 Eli Lilly Business Overview
  16. 6.3.3 Eli Lilly Non-invasive Insulin Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Eli Lilly Non-invasive Insulin Product Portfolio
  18. 6.3.5 Eli Lilly Recent Developments
  19. 6.4 Biocon
  20. 6.4.1 Biocon Company Information
  21. 6.4.2 Biocon Business Overview
  22. 6.4.3 Biocon Non-invasive Insulin Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Biocon Non-invasive Insulin Product Portfolio
  24. 6.4.5 Biocon Recent Developments
  25. 6.5 Zafgen
  26. 6.5.1 Zafgen Company Information
  27. 6.5.2 Zafgen Business Overview
  28. 6.5.3 Zafgen Non-invasive Insulin Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Zafgen Non-invasive Insulin Product Portfolio
  30. 6.5.5 Zafgen Recent Developments
  31. 6.6 Verily Life Sciences
  32. 6.6.1 Verily Life Sciences Company Information
  33. 6.6.2 Verily Life Sciences Business Overview
  34. 6.6.3 Verily Life Sciences Non-invasive Insulin Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Verily Life Sciences Non-invasive Insulin Product Portfolio
  36. 6.6.5 Verily Life Sciences Recent Developments
  37. 6.7 Senseonics
  38. 6.7.1 Senseonics Company Information
  39. 6.7.2 Senseonics Business Overview
  40. 6.7.3 Senseonics Non-invasive Insulin Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Senseonics Non-invasive Insulin Product Portfolio
  42. 6.7.5 Senseonics Recent Developments
  43. 6.8 Oramed Pharmaceuticals
  44. 6.8.1 Oramed Pharmaceuticals Company Information
  45. 6.8.2 Oramed Pharmaceuticals Business Overview
  46. 6.8.3 Oramed Pharmaceuticals Non-invasive Insulin Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Oramed Pharmaceuticals Non-invasive Insulin Product Portfolio
  48. 6.8.5 Oramed Pharmaceuticals Recent Developments
  49. 6.9 Medtronic
  50. 6.9.1 Medtronic Company Information
  51. 6.9.2 Medtronic Business Overview
  52. 6.9.3 Medtronic Non-invasive Insulin Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Medtronic Non-invasive Insulin Product Portfolio
  54. 6.9.5 Medtronic Recent Developments
  55. 6.10 MannKind Corporation
  56. 6.10.1 MannKind Corporation Company Information
  57. 6.10.2 MannKind Corporation Business Overview
  58. 6.10.3 MannKind Corporation Non-invasive Insulin Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 MannKind Corporation Non-invasive Insulin Product Portfolio
  60. 6.10.5 MannKind Corporation Recent Developments
  61. 6.11 Janssen Pharmaceuticals
  62. 6.11.1 Janssen Pharmaceuticals Company Information
  63. 6.11.2 Janssen Pharmaceuticals Business Overview
  64. 6.11.3 Janssen Pharmaceuticals Non-invasive Insulin Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Janssen Pharmaceuticals Non-invasive Insulin Product Portfolio
  66. 6.11.5 Janssen Pharmaceuticals Recent Developments
  67. 6.12 Dance Biopharm
  68. 6.12.1 Dance Biopharm Company Information
  69. 6.12.2 Dance Biopharm Business Overview
  70. 6.12.3 Dance Biopharm Non-invasive Insulin Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Dance Biopharm Non-invasive Insulin Product Portfolio
  72. 6.12.5 Dance Biopharm Recent Developments
  73. 6.13 Bigfoot Biomedical
  74. 6.13.1 Bigfoot Biomedical Company Information
  75. 6.13.2 Bigfoot Biomedical Business Overview
  76. 6.13.3 Bigfoot Biomedical Non-invasive Insulin Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Bigfoot Biomedical Non-invasive Insulin Product Portfolio
  78. 6.13.5 Bigfoot Biomedical Recent Developments
  79. 6.14 Adocia
  80. 6.14.1 Adocia Company Information
  81. 6.14.2 Adocia Business Overview
  82. 6.14.3 Adocia Non-invasive Insulin Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Adocia Non-invasive Insulin Product Portfolio
  84. 6.14.5 Adocia Recent Developments
7 North America by Country
  1. 7.1 North America Non-invasive Insulin Sales by Country
  2. 7.1.1 North America Non-invasive Insulin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Non-invasive Insulin Sales by Country (2021-2026)
  4. 7.1.3 North America Non-invasive Insulin Sales Forecast by Country (2027-2032)
  5. 7.2 North America Non-invasive Insulin Market Size by Country
  6. 7.2.1 North America Non-invasive Insulin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Non-invasive Insulin Market Size by Country (2021-2026)
  8. 7.2.3 North America Non-invasive Insulin Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Non-invasive Insulin Sales by Country
  2. 8.1.1 Europe Non-invasive Insulin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Non-invasive Insulin Sales by Country (2021-2026)
  4. 8.1.3 Europe Non-invasive Insulin Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Non-invasive Insulin Market Size by Country
  6. 8.2.1 Europe Non-invasive Insulin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Non-invasive Insulin Market Size by Country (2021-2026)
  8. 8.2.3 Europe Non-invasive Insulin Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Non-invasive Insulin Sales by Country
  2. 9.1.1 Asia-Pacific Non-invasive Insulin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Non-invasive Insulin Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Non-invasive Insulin Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Non-invasive Insulin Market Size by Country
  6. 9.2.1 Asia-Pacific Non-invasive Insulin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Non-invasive Insulin Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Non-invasive Insulin Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Non-invasive Insulin Sales by Country
  2. 10.1.1 South America Non-invasive Insulin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Non-invasive Insulin Sales by Country (2021-2026)
  4. 10.1.3 South America Non-invasive Insulin Sales Forecast by Country (2027-2032)
  5. 10.2 South America Non-invasive Insulin Market Size by Country
  6. 10.2.1 South America Non-invasive Insulin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Non-invasive Insulin Market Size by Country (2021-2026)
  8. 10.2.3 South America Non-invasive Insulin Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Non-invasive Insulin Sales by Country
  2. 11.1.1 Middle East and Africa Non-invasive Insulin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Non-invasive Insulin Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Non-invasive Insulin Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Non-invasive Insulin Market Size by Country
  6. 11.2.1 Middle East and Africa Non-invasive Insulin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Non-invasive Insulin Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Non-invasive Insulin Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Non-invasive Insulin Value Chain Analysis
  2. 12.1.1 Non-invasive Insulin Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Non-invasive Insulin Production Mode & Process
  7. 12.2 Non-invasive Insulin Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Non-invasive Insulin Distributors
  10. 12.2.3 Non-invasive Insulin Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst